Search

Earlier diagnosis and treatment, plus biological therapies, have transformed the outlook for many patients with rheumatoid arthritis. In the future, new biomarkers for diagnosis, prognosis and therapeutic response will further improve outcomes. Additionally, preclinical diagnosis and tolerogenic therapies could provide sustained remission for some individuals, although ethical and societal challenges must also be addressed before rheumatoid arthritis becomes 'yesterday's disease'. [ABSTRACT FROM AUTHOR]

The article presents review of several articles published in the "Equine Veterinary Journal" including one on endocrine function and foal birthweight by Smith and colleagues, one on nutraceuticals and synovitis by Van de Water and colleagues, and one on laminitis risk factors by Menzies-Gow anc colleagues.